Larvol Delta - Efficacy-and-Safety-of-Subcutaneous-Ustekinumab-in-Pediatric-Participants-With-Active-Juvenile-Psoriatic-Arthritis-Results-of-the-Openlabel-Phase-3-PSUMMITJr-Study-Through-Week-52

Stelara (ustekinumab) - J&J

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1899277&mode=presInfo

Hermine Brunner, MD, MSc, MBA

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next